Vitro S.A.B. de C.V Total Liabilities
Vitro S.A.B. de C.V total liabilities. Based on the latest financial reports, Vitro S.A.B. de C.V (VITROA) has total liabilities worth MX$965.25 Million MXN (≈ $55.55 Million USD) as of December 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Vitro S.A.B. de C.V to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Vitro S.A.B. de C.V (2000–2023)
Total liabilities of Vitro S.A.B. de C.V from 2000 to 2023. This chart illustrates how Vitro S.A.B. de C.V's total liabilities have evolved over time, based on quarterly financial data. Explore Vitro S.A.B. de C.V long-term investment intensity to see how much of total assets are deployed in long-term investments.
Vitro S.A.B. de C.V Competitors by Total Liabilities
The table below lists competitors of Vitro S.A.B. de C.V ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lara Exploration Ltd.
V:LRA
|
Canada | CA$266.12K |
|
Yatra Online Limited
NSE:YATRA
|
India | Rs5.06 Billion |
|
Sarfati
TA:SRFT
|
Israel | ILA1.27 Billion |
|
QRF SCA
BR:QRF
|
Belgium | €194.54 Million |
|
Sajo Ind
KO:007160
|
Korea | ₩617.05 Billion |
|
APCB Inc
TW:6108
|
Taiwan | NT$4.25 Billion |
|
Tharimmune Inc.
NASDAQ:THAR
|
USA | $114.86 Million |
|
Origin Property PCL
BK:ORI
|
Thailand | ฿42.79 Billion |
Liability Composition Analysis (2000–2023)
This chart breaks down Vitro S.A.B. de C.V's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see VITROA asset base.
Liquidity & Leverage Metrics
Vitro S.A.B. de C.V Total Liabilities Ratios Explained
Vitro S.A.B. de C.V total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vitro S.A.B. de C.V's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vitro S.A.B. de C.V (2000–2023)
The table below shows the annual total liabilities of Vitro S.A.B. de C.V from 2000 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | MX$965.25 Million ≈ $55.55 Million |
-28.62% |
| 2022-12-31 | MX$1.35 Billion ≈ $77.83 Million |
+1.00% |
| 2021-12-31 | MX$1.34 Billion ≈ $77.06 Million |
-15.69% |
| 2020-12-31 | MX$1.59 Billion ≈ $91.40 Million |
+16.47% |
| 2019-12-31 | MX$1.36 Billion ≈ $78.47 Million |
+4.68% |
| 2018-12-31 | MX$1.30 Billion ≈ $74.97 Million |
+0.84% |
| 2017-12-31 | MX$1.29 Billion ≈ $74.34 Million |
+29.20% |
| 2016-12-31 | MX$999.84 Million ≈ $57.54 Million |
-86.82% |
| 2015-12-31 | MX$7.59 Billion ≈ $436.69 Million |
-71.88% |
| 2014-12-31 | MX$26.98 Billion ≈ $1.55 Billion |
-0.23% |
| 2013-12-31 | MX$27.05 Billion ≈ $1.56 Billion |
-9.62% |
| 2012-12-31 | MX$29.93 Billion ≈ $1.72 Billion |
-6.95% |
| 2011-12-31 | MX$32.16 Billion ≈ $1.85 Billion |
+6.40% |
| 2010-12-31 | MX$30.23 Billion ≈ $1.74 Billion |
-1.44% |
| 2009-12-31 | MX$30.67 Billion ≈ $1.76 Billion |
-0.56% |
| 2008-12-31 | MX$30.84 Billion ≈ $1.77 Billion |
+35.26% |
| 2007-12-31 | MX$22.80 Billion ≈ $1.31 Billion |
+25.08% |
| 2006-12-31 | MX$18.23 Billion ≈ $1.05 Billion |
-16.17% |
| 2005-12-31 | MX$21.75 Billion ≈ $1.25 Billion |
-5.78% |
| 2004-12-31 | MX$23.08 Billion ≈ $1.33 Billion |
+3.81% |
| 2003-12-31 | MX$22.23 Billion ≈ $1.28 Billion |
+3.80% |
| 2002-12-31 | MX$21.42 Billion ≈ $1.23 Billion |
-4.72% |
| 2001-12-31 | MX$22.48 Billion ≈ $1.29 Billion |
-1.61% |
| 2000-12-31 | MX$22.85 Billion ≈ $1.31 Billion |
-- |
About Vitro S.A.B. de C.V
Vitro, S.A.B. de C.V., through its subsidiaries, produces, processes, distributes, and markets inorganic chemical products worldwide. The company provides sodium carbonate and bicarbonate, calcium chloride, and sodium chloride. It serves automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors. Vitro, S.A.B. de C.V. was founded in 1909 and is b… Read more